Ketamine-induced modulation of the thalamo-cortical network in healthy volunteers as a model for schizophrenia

International Journal of Neuropsychopharmacology

Volumn 18, Issue 9, 2015, Pages 1-11

  Höflich, Anna ^a   Hahn, Andreas ^a   Küblböck, Martin ^a   Kranz, Georg S ^a   Vanicek, Thomas ^a   Windischberger, Christian ^a   Saria, Alois ^b   Kasper, Siegfried ^a   Winkler, Dietmar ^a   Lanzenberger, Rupert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Functional MRI; Glutamate; Ketamine; Schizophrenia; Thalamus

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; AMINO ACID RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; ARTIFICIAL NEURAL NETWORK; BODY WEIGHT; BOLD SIGNAL; BRAIN VENTRICLE; BRIEF PSYCHIATRIC RATING SCALE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DSM-IV; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL CORTEX; OCCIPITAL LOBE; POSITIVE AND NEGATIVE SYNDROME SCALE; POSTERIOR PARIETAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SOMATOSENSORY CORTEX; TEMPORAL LOBE; THALAMO CORTICAL NETWORK; THALAMUS HUB NETWORK; WHITE MATTER; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; NERVE CELL NETWORK; PATHOPHYSIOLOGY; THALAMUS; YOUNG ADULT;

ADULT; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; KETAMINE; MALE; NERVE NET; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SOMATOSENSORY CORTEX; TEMPORAL LOBE; THALAMUS; YOUNG ADULT;

EID: 85016649797     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv040     Document Type: Article

References (64)

1. Abel KM, Allin MP, Kucharska-Pietura K, David A., Andrew C, Williams S, Brammer M.J., Phillips M.L. (2003) Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. Neuroreport 14:387-391.
2. Adolphs R (2003) Investigating the cognitive neuroscience of social behavior. Neuropsychologia 41:119-126.
3. Alonso-Solís A, Corripio I, de Castro-Manglano P, Duran-Sindreu S, Garcia-Garcia M, Proal E, Nuñez-Marín F, Soutullo C, Alvarez E, Gómez-Ansón B, Kelly C, Castellanos FX (2012) Altered default network resting state functional connectivity in patients with a first episode of psychosis. Schizophr Res 139:13-18.
4. Anticevic A, Gancsos M, Murray J.D., Repovs G., Driesen NR, Ennis DJ, Niciu MJ, Morgan P.T., Surti TS, Bloch MH, Ramani R, Smith M.A., Wang XJ, Krystal JH, Corlett P.R. (2012) NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proc Natl Acad Sci U S A 109:16720-16725.
5. Behrens TE, Johansen-Berg H, Woolrich M.W., Smith SM, Wheeler-Kingshott CA, Boulby PA, Barker G.J., Sillery EL, Sheehan K, Ciccarelli O, Thompson A.J., Brady JM, Matthews P.M. (2003) Noninvasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 6:750-757.
6. Biswal B, Yetkin FZ, Haughton V.M., Hyde J.S. (1995) Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 34:537-541.
7. Bustillo JR, Rowland LM, Mullins P, Jung R., Chen H, Qualls C, Hammond R., Brooks WM, Lauriello J. (2010) 1H-MRS at 4 tesla in minimally treated early schizophrenia. Mol Psychiatry 15:629-636.
8. Celada P, Llado-Pelfort L, Santana N., Kargieman L, Troyano-Rodriguez E, Riga MS, Artigas F. (2013) Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action. Int J Neuropsychopharmacol: 1-19.
9. Chang C, Metzger CD, Glover G.H., Duyn JH, Heinze HJ, Walter M. (2013) Association between heart rate variability and fluctuations in resting-state functional connectivity. Neuroimage 68:93-104.
10. Clinton SM, Meador-Woodruff JH (2004) Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophr Res 69:237-253.
11. Cole DM, Smith SM, Beckmann C.F. (2010) Advances and pitfalls in the analysis and interpretation of resting-state FMRI data. Front Syst Neurosci 4:8.
12. Daumann J, Wagner D, Heekeren K., Neukirch A, Thiel CM, Gouzoulis-Mayfrank E (2010) Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis. J Psychopharmacol 24:1515-1524.
13. Dichter GS, Felder JN, Smoski M.J. (2009) Affective context interferes with cognitive control in unipolar depression: an fMRI investigation. J Affect Disord 114:131-142.
14. Dittrich A (1998) The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry 31 Suppl 2:80-84.
15. Driesen NR, McCarthy G, Bhagwagar Z., Bloch M, Calhoun V, D'Souza DC, Gueorguieva R, He G., Ramachandran R, Suckow RF, Anticevic A, Morgan P.T., Krystal J.H. (2013) Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Mol Psychiatry 18:1199-1204.
16. Egerton A, Brugger S, Raffin M., Barker GJ, Lythgoe DJ, McGuire PK, Stone J.M. (2012) Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology 37:2515-2521.
17. Falkenberg LE, Westerhausen R, Specht K., Hugdahl K. (2012) Resting-state glutamate level in the anterior cingulate predicts blood-oxygen level-dependent response to cognitive control. Proc Natl Acad Sci U S A 109:5069-5073.
18. Fu CH, Williams SC, Cleare A.J., Brammer MJ, Walsh ND, Kim J, Andrew C.M., Pich EM, Williams PM, Reed LJ, Mitterschiffthaler M.T., Suckling J., Bullmore E.T. (2004) Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61:877-889.
19. Gluck MR, Thomas RG, Davis K.L., Haroutunian V. (2002) Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am J Psychiatry 159:1165-1173.
20. Gsell W, Burke M, Wiedermann D., Bonvento G, Silva AC, Dauphin F, Buhrle C., Hoehn M, Schwindt W. (2006) Differential effects of NMDA and AMPA glutamate receptors on functional magnetic resonance imaging signals and evoked neuronal activity during forepaw stimulation of the rat. J Neurosci 26:8409-8416.
21. Hahn A, Stein P, Windischberger C., Weissenbacher A, Spindelegger C, Moser E., Kasper S, Lanzenberger R. (2011) Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder. Neuroimage 56:881-889.
22. Hahn A, Kranz GS, Seidel E.M., Sladky R., Kraus C, Kublbock M, Pfabigan D.M., Hummer A., Grahl A, Ganger S, Windischberger C., Lamm C, Lanzenberger R. (2013) Comparing neural response to painful electrical stimulation with functional MRI at 3 and 7T. Neuroimage 82C:336-343.
23. Hoflich A, Baldinger P, Savli M., Lanzenberger R, Kasper S. (2012) Imaging treatment effects in depression. Rev Neurosci 23:227-252.
24. Kasai K, Shenton ME, Salisbury D.F., Hirayasu Y., Lee CU, Ciszewski AA, Yurgelun-Todd D, Kikinis R, Jolesz F.A., McCarley R.W. (2003) Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry 160:156-164.
25. Kegeles LS, Mao X, Stanford A.D., Girgis R., Ojeil N, Xu X, Gil R., Slifstein M, Abi-Dargham A, Lisanby SH, Shungu D.C. (2012) Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry 69:449-459.
26. Klingner CM, Langbein K, Dietzek M., Smesny S, Witte OW, Sauer H, Nenadic I. (2013) Thalamocortical connectivity during resting state in schizophrenia. Eur Arch Psychiatry Clin Neurosci 264:111-119.
27. Kornhuber J, Mack-Burkhardt F, Riederer P., Hebenstreit GF, Reynolds GP, Andrews HB, Beckmann H. (1989) [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. J Neural Transm 77:231-236.
28. Leitman DI, Sehatpour P, Higgins B.A., Foxe JJ, Silipo G, Javitt D.C. (2010) Sensory deficits and distributed hierarchical dysfunction in schizophrenia. Am J Psychiatry 167:818-827.
29. Lesh TA, Niendam TA, Minzenberg M.J., Carter C.S. (2011) Cognitive control deficits in schizophrenia: mechanisms and meaning. Neuropsychopharmacology 36:316-338.
30. Li N, Lee B, Liu R.J., Banasr M., Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman R.S. (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329:959-964.
31. Li N, Liu RJ, Dwyer J.M., Banasr M., Lee B, Son H, Li X.Y., Aghajanian G., Duman R.S. (2011) Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 69:754-761.
32. Lopez-Gil X., Babot Z, Amargos-Bosch M, Sunol C., Artigas F, Adell A. (2007) Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat. Neuropsychopharmacology 32:2087-2097.
33. Lorrain DS, Baccei CS, Bristow L.J., Anderson JJ, Varney M.A. (2003) Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117:697-706.
34. McKie S, Del-Ben C, Elliott R., Williams S, del Vai N, Anderson I, Deakin J.F. (2005) Neuronal effects of acute citalopram detected by pharmacoMRI. Psychopharmacology (Berl) 180:680-686.
35. Meador-Woodruff J.H., Clinton SM, Beneyto M, McCullumsmith R.E. (2003) Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia. Ann NY Acad Sci 1003:75-93.
36. Metzger CD, van der Werf YD, Walter M (2013) Functional mapping of thalamic nuclei and their integration into corticostriatal-thalamo-cortical loops via ultra-high resolution imaging-from animal anatomy to in vivo imaging in humans. Front Neurosci 7:24.
37. Musso F, Brinkmeyer J, Ecker D., London MK, Thieme G, Warbrick T, Wittsack H.J., Saleh A., Greb W, de Boer P, Winterer G. (2011) Ketamine effects on brain function: simultaneous fMRI/EEG during a visual oddball task. Neuroimage 58:508-525.
38. Power JD, Barnes KA, Snyder A.Z., Schlaggar BL, Petersen S.E. (2012) Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 59:2142-2154.
39. Radua J, Phillips ML, Russell T, Lawrence N., Marshall N, Kalidindi S, El-Hage W, McDonald C., Giampietro V, Brammer MJ, David A.S., Surguladze S.A. (2010) Neural response to specific components of fearful faces in healthy and schizophrenic adults. Neuroimage 49:939-946.
40. Rowland LM, Bustillo JR, Mullins P.G., Jung RE, Lenroot R, Landgraf E, Barrow R., Yeo R, Lauriello J, Brooks W.M. (2005) Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry 162:394-396.
41. Santana N, Troyano-Rodriguez E, Mengod G., Celada P, Artigas F. (2011) Activation of thalamocortical networks by the N-methyl-D-aspartate receptor antagonist phencyclidine: reversal by clozapine. Biol Psychiatry 69:918-927.
42. Scheidegger M, Walter M, Lehmann M., Metzger C, Grimm S, Boeker H., Boesiger P, Henning A, Seifritz E. (2012) Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action. PLoS One 7:e44799.
43. Seymour K, Stein T, Sanders L.L., Guggenmos M., Theophil I, Sterzer P. (2013) Altered contextual modulation of primary visual cortex responses in schizophrenia. Neuropsychopharmacology 38:2607-2612.
44. Sim K, Cullen T, Ongur D., Heckers S. (2006) Testing models of thalamic dysfunction in schizophrenia using neuroimaging. J Neural Transm 113:907-928.
45. Sinner B, Graf B. (2008) Ketamine. In: Modern anesthetics. Handbook of experimental pharmacology (Schüttler J, Schwilden H, eds), pp 313-333. Berlin, Heidelberg: Springer.
46. Smith MJ, Wang L, Cronenwett W., Mamah D, Barch DM, Csernansky J.G. (2011) Thalamic morphology in schizophrenia and schizoaffective disorder. J Psychiatr Res 45:378-385.
47. Sommer IE, Clos M, Meijering A.L., Diederen KM, Eickhoff S.B. (2012) Resting state functional connectivity in patients with chronic hallucinations. PLoS One 7:e43516.
48. Stone JM, Abel KM, Allin M.P., van Haren N, Matsumoto K, McGuire P.K., Fu C.H. (2011) Ketamine-induced disruption of verbal self-monitoring linked to superior temporal activation. Pharmacopsychiatry 44:33-48.
49. Stone JM, Dietrich C, Edden R., Mehta MA, De Simoni S, Reed LJ, Krystal J.H., Nutt D., Barker G.J. (2012) Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology. Mol Psychiatry 17:664-665.
50. Szulc A, Konarzewska B, Galinska-Skok B, Lazarczyk J., Waszkiewicz N, Tarasow E, Milewski R., Walecki J. (2013) Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia. Neurosci Lett 547:37-41.
51. Taylor MJ, Tiangga ER, Mhuircheartaigh R.N., Cowen P.J. (2012) Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study. J Psychopharmacol 26:733-737.
52. Theberge J, Bartha R, Drost D.J., Menon RS, Malla A, Takhar J, Neufeld R.W., Rogers J., Pavlosky W, Schaefer B, Densmore M., Al-Semaan Y, Williamson P.C. (2002) Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry 159:1944-1946.
53. Tomasi D, Volkow N.D. (2011) Association between functional connectivity hubs and brain networks. Cereb Cortex 21:2003-2013.
54. Troyano-Rodriguez E., Llado-Pelfort L, Santana N., Teruel-Marti V, Celada P, Artigas F. (2014) Phencyclidine inhibits the activity of thalamic reticular gamma-aminobutyric acidergic neurons in rat brain. Biol Psychiatry 76:937-945.
55. Tu P-C, Lee Y-C, Chen Y-S, Li C-T, Su T-P (2013) Schizophrenia and the brain's control network: aberrant within- and between-network connectivity of the frontoparietal network in schizophrenia. Schizophr Res 147:339-347.
56. Tzourio-Mazoyer N., Landeau B, Papathanassiou D., Crivello F, Etard O, Delcroix N., Mazoyer B, Joliot M. (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273-289.
57. Watis L, Chen SH, Chua H.C., Chong SA, Sim K. (2008) Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review. J Neural Transm 115:493-511.
58. Weissenbacher A, Kasess C, Gerstl F., Lanzenberger R, Moser E, Windischberger C. (2009) Correlations and anticorrelations in resting-state functional connectivity MRI: a quantitative comparison of preprocessing strategies. Neuroimage 47:1408-1416.
59. Whitfield-Gabrieli S., Ford J.M. (2012) Default mode network activity and connectivity in psychopathology. Ann Rev Clin Psychol 8:49-76.
60. Woodward ND, Karbasforoushan H, Heckers S. (2012) Thalamocortical dysconnectivity in schizophrenia. Am J Psychiatry 169:1092-1099.
61. Zhang D, Snyder AZ, Shimony J.S., Fox MD, Raichle M.E. (2010) Noninvasive functional and structural connectivity mapping of the human thalamocortical system. Cereb Cortex 20:1187-1194.
62. Zhang D, Snyder AZ, Fox M.D., Sansbury MW, Shimony JS, Raichle M.E. (2008) Intrinsic functional relations between human cerebral cortex and thalamus. J Neurophysiol 100:1740-1748.
63. Zhang Y, Yoshida T, Katz D.B., Lisman J.E. (2012) NMDAR antagonist action in thalamus imposes delta oscillations on the hippocampus. J Neurophysiol 107:3181-3189.
64. Zhou Y, Liang M, Tian L., Wang K, Hao Y, Liu H., Liu Z, Jiang T. (2007) Functional disintegration in paranoid schizophrenia using resting-state fMRI. Schizophr Res 97:194-205.